米尔纳奇普兰
冲动性
注意缺陷多动障碍
心理学
精神科
临床心理学
评定量表
发展心理学
焦虑
抗抑郁药
作者
Hirobumi Mashiko,Hiromichi Ishikawa,Shuntaro Itagaki,Yasuko Takanashi,Norihiro Miyashita,Takaaki Okano,Shin‐Ichi Niwa,Hirooki Yabe
出处
期刊:Open Journal of Psychiatry
[Scientific Research Publishing, Inc.]
日期:2014-01-01
卷期号:04 (03): 195-201
被引量:3
标识
DOI:10.4236/ojpsych.2014.43026
摘要
The efficacy of milnacipran for the treatment of ADHD symptoms in adult Asperger’s disorder patients was examined. Fifteen consecutive adult Asperger’s disorder patients with ADHD symptoms were treated with milnacipran for 8 weeks. Global Assessment of Functioning (GAF) and Conners’ Adult ADHD Rating Scales Objective Screening Version (CAARS-O-SV) were used for the assessment. The mean GAF scores in the 15 patients improved significantly. Inattention, inattention + hyperactivity/impulsivity and ADHD index in CAARS-O-SV were also significantly improved. Milnacipran might be useful for ADHD symptoms, exerting its effects by increasing serotonin and noradrenaline activities in Asperger’s disorder.
科研通智能强力驱动
Strongly Powered by AbleSci AI